Selling pressure pushes Palantir stock lower in today's trading

Traders Union
All News
Financial News
Palantir slides 4.62% today to $145.34

Highlights

Palantir posted exceptional Q1 2026 results, reporting 85% year-over-year revenue growth and a Rule of 40 score of 145.
The firm broadened its industry footprint through a construction-sector channel partnership and faces regulatory scrutiny over its £330 million NHS contract in the UK.
Technicals show short- and medium-term momentum, but with price below long-term resistance and a baseline scenario favoring sideways movement in the $141.50 to $149.37 range.

Revenue surge and UK scrutiny temper market sentiment despite new deals

In the first quarter of 2026, Palantir reported revenue growth of 85% year-over-year and achieved a Rule of 40 score of 145. The company recently expanded its partnership with Thomas Cavanagh Construction Limited, with Cavanagh serving as a channel partner to deploy Palantir's Foundry platform in the construction industry. Separately, Palantir's £330 million NHS contract in the UK was subject to scrutiny from UK Members of Parliament regarding national security concerns, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, believes Palantir's price action exposes persistent structural weaknesses despite recent positive momentum. He sees overbought signals in technical indicators and doubts the sustainability of current gains, especially with the price still well below the 200-day average. Kharitonov highlights the mixed performance of oscillators and weak ADX as evidence of unresolved short-term direction. He notes that fundamental developments, such as the NHS contract scrutiny, continue to weigh on sentiment. "Until Palantir breaks decisively above $149.37 or addresses long-term pressure, any upside looks fragile to me," he warns.

Viktoras Karapetjanc, expert at Traders Union, points to the company's robust 85% revenue growth and stellar Rule of 40 score as signs of resilient fundamentals. He expects that the expanded industry partnerships and strong institutional adoption will support ongoing momentum. Karapetjanc asserts that the bullish structure remains intact above key medium-term support levels. He sees current volatility as a healthy setup for potential breakout plays. "With Palantir's growth story deepening, I see further upside likely if $149.37 is cleared on solid volume," he says.

Support at key moving averages as mixed momentum clouds direction

Immediate dynamic support appears at the Ichimoku Kijun around $146.22, while the 50-day moving average near $142 forms a key underlying level and the next resistance is likely at the round $150 area. Momentum indicators present mixed signals, with the MACD (4.48) indicating a continuing upward trend on the daily chart, but the Average Directional Index (ADX) at 11.95 signals weak trend strength. The Relative Strength Index (RSI) at 59.90 is in bullish territory, while the Stochastic RSI and Commodity Channel Index (CCI) are both flagging overbought conditions. Bull/Bear Power (BBP) at 9.67 shows buyers dominating intraday action, though the overbought warning underscores heightened demand. Price action shows clear pressure after the open, with divergence between daily oscillators and momentum indicators highlighting ongoing uncertainty in short-term direction and a mostly negative immediate market tone.

Previously it was reported that Palantir's upside was constrained by mounting regulatory risk in the UK and technical indicators pointing to short-term vulnerability. With the current mix of strong commercial execution and continued overbought warning signals, traders should monitor for resolution of price action near $149.37 resistance, as a breakout or breakdown from this zone could define the next directional move.

Source of Data: PLTR Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.